Letters to the Editor

Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib

Hematology Unit, Department of Medicine, University of Padova, Padova
ASST Spedali Civili, Brescia, Department of Hematology, Brescia
Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna
Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Meldola
Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”, Meldola, Meldola, Italy; Hematology Unit, Department of Medical and Surgical Sciences, University of Bologna, Ospedale S. Maria delle Croci, Ravenna
Hematology Unit, Department of Engineering and Innovation Medicine, University of Verona, Verona, Verona
Hematology Unit, Division of Hematology, Valduce Hospital, Como, Como
Hematology and Stem Cell Transplant Center, AST 1, Pesaro, Pesaro
Department of Oncology, Division of Hematology, AOU City of Health and Science of Turin, Turin
Hematology and Stem Cell Transplant Unit, Presidio Ospedaliero “Vito Fazzi”, Lecce, Lecce
Hematology and BMT Unit, Azienda Ospedaliero Universitaria Policlinico “G. Rodolico-San Marco”, Catania, Catania
University of Naples Federico II, Napoli
Hematology Unit, Department of Medicine, University of Padova, Padova
Division of Hematology, AORN Cardarelli, Naples, Napoli
Hematology Unit, Department of Medicine, University of Padova, Padova
Hematology Unit, Department of Medicine, University of Padova, Padova
Hematology Unit, Department of Medicine, University of Padova, Padova
Haematologica Early view Apr 9, 2026 https://doi.org/10.3324/haematol.2026.300540